pH dependent inhibition from ammonium ions in the Pseudomonas mevalonii HMG-CoA Reductase crystallization environment

Vatsal Purohit, C.n. Steussy, Anthony R. Rosales, Chandra J. Critchelow, Tim Schmidt, Paul Helquist, Olaf Wiest, Andrew D. Mesecar, Cynthia V. StauffacherbioRxiv 2020 · DOI

TL;DR

This study investigates why Pseudomonas mevalonii HMG-CoA reductase (pmHMGR) is inactive in crystal structures when bound to its natural substrates (mevalonate, CoA, NAD). Researchers found that ammonium ions, commonly found in crystallization buffers, significantly inhibit enzyme activity in a pH-dependent manner, likely by interfering with the initial hydride transfer step. This work is crucial for understanding enzyme mechanisms in crystalline environments and for developing new antibacterial strategies.

What Problem Does This Paper Address?

HMG-CoA reductase (HMGR) is a vital enzyme involved in the biosynthesis of cholesterol and isoprenoids, and it's essential for the survival of certain antibiotic-resistant bacteria. While its general catalytic mechanism involving two hydride transfers is understood, the precise details of intermediate formation, cofactor exchange, and product release remain elusive. Structural studies are key to unraveling these mechanisms, but a significant problem arises when enzymes are crystallized: they often become catalytically inactive. Specifically, pmHMGR is active in crystals when bound to modified substrates (dithio-HMG-CoA and NADH) but inactive when bound to its natural substrates (mevalonate, CoA, and NAD). This paper aims to pinpoint the cause of this inactivity in the natural substrate complex within the crystal environment.

Methods

The researchers employed a multi-pronged approach:

  • Enzymatic Activity Assays: They measured the enzyme's turnover rate (production of NADH) across a range of pH values using different buffer conditions. This allowed them to assess how various components of the crystallization buffer affected enzyme activity.
  • Kinetic Measurements (Km): They determined the Michaelis constants (Km) for mevalonate, CoA, and NAD in both standard enzymatic assay conditions and the crystallization buffer. Km reflects the enzyme's affinity for its substrates, and changes in Km can indicate inhibition or altered binding.
  • X-ray Crystallography: They solved crystal structures of pmHMGR bound to:
  • Mevalonate, CoA, and NAD (the inactive quaternary complex).
  • Mevaldehyde and CoA (a post-turnover intermediate). These structures provided direct visual evidence of ligand binding and potential reaction intermediates within the crystal.

  • Structural Analysis: They analyzed the electron density maps from the crystal structures to identify the positions of ligands and any formed intermediates, comparing them to known structures and theoretical models.

Datasets

Not discussed in the paper. The study focuses on experimental data derived from enzyme assays and structural analysis of purified enzyme.

Key Insights and Ideas

  • Ammonium is the Culprit: The most significant finding is that ammonium ions (NH₄⁺) are the primary inhibitors of pmHMGR activity within the crystallization buffer. This was demonstrated by observing similar inhibition patterns with various ammonium salts and a lack of inhibition in buffers lacking ammonium.
  • pH-Dependent Inhibition: The inhibition by ammonium is strongly pH-dependent. Activity increases as the pH rises above the pKa of ammonium (around 9.3), suggesting that the neutral ammonia form (NH₃) is less inhibitory or that the deprotonated form of the enzyme is more active.
  • Targeted Inhibition of the First Hydride Transfer: Kinetic data (reduced Km for NAD and mevalonate) strongly suggests that ammonium inhibits the initial hydride transfer step, where mevalonate is converted to mevaldehyde.
  • Crystal Environment vs. Solution: The study highlights how the unique environment within a crystal can drastically alter enzyme behavior, even when the enzyme is known to be catalytically competent in solution or with modified substrates.
  • Structural Evidence of Trapped Intermediate: The crystal structure of pmHMGR bound to mevaldehyde and CoA shows a thiohemiacetal intermediate, indicating that the enzyme can proceed past the first hydride transfer but is likely inhibited from completing the subsequent steps within the crystal.

Key Results

  • Significant Activity Reduction: Enzyme turnover in the crystallization buffer (1.2 M ammonium sulfate) was significantly lower across all tested pH values compared to the standard enzymatic assay buffer.
  • Km Changes: The Km values for NAD and mevalonate were drastically reduced in the crystallization buffer (9.25-fold and 3.67-fold, respectively) compared to standard conditions, indicating a much lower affinity for these substrates in the crystal. The Km for CoA also decreased, but to a lesser extent.
  • pH-Activity Profile: The pH-activity profile in the crystallization buffer showed a sharp decrease in activity from pH 4-11, with a shift in optimal pH from 9 to 10. This pattern was consistent across different ammonium salt buffers.
  • Structural Confirmation: X-ray crystallography confirmed the binding of mevalonate, CoA, and NAD in the quaternary complex but showed no evidence of product formation. A separate structure with mevaldehyde and CoA revealed a trapped thiohemiacetal intermediate.

Limitations and Future Work

  • Incomplete Reaction Pathway: While the study identified the inhibition of the first hydride transfer, it did not fully elucidate the mechanism of inhibition for the second hydride transfer step.
  • Specific Binding Site of Ammonium: The exact binding site and mode of interaction of ammonium ions with the enzyme are not definitively shown, although a model proposing binding to the anionic Glu 83 is suggested.
  • Future Directions: The authors suggest that understanding this pH-dependent inhibition by ammonium is crucial for developing strategies to overcome it. This could involve modifying crystallization conditions or using inhibitors that target the ammonium binding site. Obtaining structures of post-turnover complexes would provide further insights into the later stages of the HMGR reaction mechanism. The findings also pave the way for designing more effective antibacterial agents by targeting this essential enzyme.

Summary updated

Abstract

ABSTRACT HMG-CoA reductase ( Pseudomonas mevalonii ) utilizes mevalonate, coenzyme A (CoA) and the cofactor NAD in a complex mechanism involving two hydride transfers with cofactor exchange, accompanied by large conformational changes by a 50 residue subdomain, to generate HMG-CoA. Details about this mechanism such as the conformational changes that allow intermediate formation, cofactor exchange and product release remain unknown. The formation of the proposed intermediates has also not been observed in structural studies with natural substrates. Having been shown to be an essential enzyme for the survival of gram-positive antibiotic resistant pathogenic bacteria, studying its mechanism in detail will be beneficial in developing novel antibacterials. The enzyme has been shown to be catalytically active inside the crystal with dithio-HMG-CoA and NADH but curiously is found to be inactive in the reverse direction in the structure bound to mevalonate, CoA and NAD. To understand the factors limiting activity in the HMGR crystal with mevalonate, CoA and NAD, we studied the effect of crystallization components and pH on enzymatic activity. We observed a strong inhibition in the crystallization buffer and an increase in activity with increasing pH. We attribute this inhibitive effect to the presence of ammonium ions present in the crystal since inhibition is also observed with several other ammonium salt buffers. Additionally, the lack of inhibition was observed in the absence of ammonium. The effect of each ligand (mevalonate, CoA and NAD) on the rate of the enzymatic reaction in the crystallization environment was further investigated by measuring their K m in the crystallization buffer. The K m measurements indicate that the hydride transfer step between NAD and mevalonate is inhibited in the crystallization environment. To test this further, we solved a crystal structure of pmHMGR bound to the post-hydride transfer intermediate (mevaldehyde) and cofactor Coenzyme A. The resulting turnover with the formation of a thiohemiacetal indicated that the crystallization environment inhibited the oxidative acylation of mevalonate and the reaction intermediate mevaldyl-CoA.
BibTeX
@misc{purohit2020ph,
  author = {Vatsal Purohit and C.N. Steussy and Anthony R. Rosales and Chandra J. Critchelow and Tim Schmidt and Paul Helquist and Olaf Wiest and Andrew D. Mesecar and Cynthia V. Stauffacher},
  title = {{pH dependent inhibition from ammonium ions in the Pseudomonas mevalonii HMG-CoA Reductase crystallization environment}},
  year = {2020},
  doi = {10.1101/2020.06.03.132290},
  howpublished = {bioRxiv},
}
Figure